vs

Side-by-side financial comparison of Fortinet (FTNT) and BeOne Medicines Ltd. (ONC). Click either name above to swap in a different company.

Fortinet is the larger business by last-quarter revenue ($1.8B vs $1.5B, roughly 1.2× BeOne Medicines Ltd.). Fortinet runs the higher net margin — 28.9% vs 4.4%, a 24.5% gap on every dollar of revenue. On growth, BeOne Medicines Ltd. posted the faster year-over-year revenue change (32.8% vs 20.1%). Fortinet produced more free cash flow last quarter ($1.0B vs $379.8M). Over the past eight quarters, BeOne Medicines Ltd.'s revenue compounded faster (41.2% CAGR vs 13.6%).

Fortinet, Inc. is an American cybersecurity company headquartered in Sunnyvale, California. It develops and sells security products including firewalls, endpoint security and intrusion detection systems. Fortinet has offices in the US, Canada, and UK.

BeOne Medicines, formerly known as BeiGene, Ltd. is a multinational oncology company. It specializes in the development of drugs for cancer treatment.

FTNT vs ONC — Head-to-Head

Bigger by revenue
FTNT
FTNT
1.2× larger
FTNT
$1.8B
$1.5B
ONC
Growing faster (revenue YoY)
ONC
ONC
+12.7% gap
ONC
32.8%
20.1%
FTNT
Higher net margin
FTNT
FTNT
24.5% more per $
FTNT
28.9%
4.4%
ONC
More free cash flow
FTNT
FTNT
$626.7M more FCF
FTNT
$1.0B
$379.8M
ONC
Faster 2-yr revenue CAGR
ONC
ONC
Annualised
ONC
41.2%
13.6%
FTNT

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
FTNT
FTNT
ONC
ONC
Revenue
$1.8B
$1.5B
Net Profit
$534.5M
$66.5M
Gross Margin
80.3%
90.5%
Operating Margin
31.4%
12.4%
Net Margin
28.9%
4.4%
Revenue YoY
20.1%
32.8%
Net Profit YoY
143.8%
EPS (diluted)
$0.72
$0.05

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FTNT
FTNT
ONC
ONC
Q1 26
$1.8B
Q4 25
$1.9B
$1.5B
Q3 25
$1.7B
$1.4B
Q2 25
$1.6B
$1.3B
Q1 25
$1.5B
$1.1B
Q4 24
$1.7B
$1.1B
Q3 24
$1.5B
$1.0B
Q2 24
$1.4B
$929.2M
Net Profit
FTNT
FTNT
ONC
ONC
Q1 26
$534.5M
Q4 25
$506.0M
$66.5M
Q3 25
$473.9M
$124.8M
Q2 25
$440.1M
$94.3M
Q1 25
$433.4M
$1.3M
Q4 24
$526.2M
$-151.9M
Q3 24
$539.9M
$-121.3M
Q2 24
$379.8M
$-120.4M
Gross Margin
FTNT
FTNT
ONC
ONC
Q1 26
80.3%
Q4 25
79.6%
90.5%
Q3 25
80.8%
86.1%
Q2 25
80.7%
87.5%
Q1 25
81.0%
85.2%
Q4 24
81.1%
85.8%
Q3 24
82.5%
83.0%
Q2 24
80.8%
85.1%
Operating Margin
FTNT
FTNT
ONC
ONC
Q1 26
31.4%
Q4 25
32.8%
12.4%
Q3 25
31.7%
11.5%
Q2 25
28.1%
6.7%
Q1 25
29.5%
1.0%
Q4 24
34.6%
-7.0%
Q3 24
31.2%
-12.0%
Q2 24
30.5%
-11.5%
Net Margin
FTNT
FTNT
ONC
ONC
Q1 26
28.9%
Q4 25
26.6%
4.4%
Q3 25
27.5%
8.8%
Q2 25
27.0%
7.2%
Q1 25
28.1%
0.1%
Q4 24
31.7%
-13.5%
Q3 24
35.8%
-12.1%
Q2 24
26.5%
-13.0%
EPS (diluted)
FTNT
FTNT
ONC
ONC
Q1 26
$0.72
Q4 25
$0.67
$0.05
Q3 25
$0.62
$0.08
Q2 25
$0.57
$0.06
Q1 25
$0.56
$0.00
Q4 24
$0.68
$-0.10
Q3 24
$0.70
$-0.09
Q2 24
$0.49
$-0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FTNT
FTNT
ONC
ONC
Cash + ST InvestmentsLiquidity on hand
$3.3B
$4.5B
Total DebtLower is stronger
$496.8M
$836.4M
Stockholders' EquityBook value
$989.7M
$4.4B
Total Assets
$9.9B
$8.2B
Debt / EquityLower = less leverage
0.50×
0.19×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FTNT
FTNT
ONC
ONC
Q1 26
$3.3B
Q4 25
$2.5B
$4.5B
Q3 25
$2.0B
$4.0B
Q2 25
$3.4B
$2.8B
Q1 25
$3.6B
$2.5B
Q4 24
$2.9B
$2.6B
Q3 24
$2.5B
$2.7B
Q2 24
$2.2B
$2.6B
Total Debt
FTNT
FTNT
ONC
ONC
Q1 26
$496.8M
Q4 25
$836.4M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
FTNT
FTNT
ONC
ONC
Q1 26
$989.7M
Q4 25
$1.2B
$4.4B
Q3 25
$735.1M
$4.1B
Q2 25
$2.1B
$3.8B
Q1 25
$2.0B
$3.5B
Q4 24
$1.5B
$3.3B
Q3 24
$908.1M
$3.4B
Q2 24
$288.2M
$3.4B
Total Assets
FTNT
FTNT
ONC
ONC
Q1 26
$9.9B
Q4 25
$10.4B
$8.2B
Q3 25
$9.4B
$7.6B
Q2 25
$10.6B
$6.3B
Q1 25
$10.4B
$5.8B
Q4 24
$9.8B
$5.9B
Q3 24
$8.9B
$5.8B
Q2 24
$8.1B
$5.7B
Debt / Equity
FTNT
FTNT
ONC
ONC
Q1 26
0.50×
Q4 25
0.19×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FTNT
FTNT
ONC
ONC
Operating Cash FlowLast quarter
$1.1B
$417.3M
Free Cash FlowOCF − Capex
$1.0B
$379.8M
FCF MarginFCF / Revenue
54.4%
25.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
2.02×
6.28×
TTM Free Cash FlowTrailing 4 quarters
$2.4B
$941.7M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FTNT
FTNT
ONC
ONC
Q1 26
$1.1B
Q4 25
$620.2M
$417.3M
Q3 25
$655.2M
$402.6M
Q2 25
$451.9M
$263.6M
Q1 25
$863.3M
$44.1M
Q4 24
$477.6M
$75.2M
Q3 24
$608.1M
$188.4M
Q2 24
$342.0M
$-95.6M
Free Cash Flow
FTNT
FTNT
ONC
ONC
Q1 26
$1.0B
Q4 25
$577.4M
$379.8M
Q3 25
$567.5M
$354.5M
Q2 25
$284.1M
$219.8M
Q1 25
$796.8M
$-12.3M
Q4 24
$380.0M
$-17.3M
Q3 24
$571.8M
$54.7M
Q2 24
$318.9M
$-205.5M
FCF Margin
FTNT
FTNT
ONC
ONC
Q1 26
54.4%
Q4 25
30.3%
25.4%
Q3 25
32.9%
25.1%
Q2 25
17.4%
16.7%
Q1 25
51.8%
-1.1%
Q4 24
22.9%
-1.5%
Q3 24
37.9%
5.5%
Q2 24
22.2%
-22.1%
Capex Intensity
FTNT
FTNT
ONC
ONC
Q1 26
Q4 25
2.2%
2.5%
Q3 25
5.1%
3.4%
Q2 25
10.3%
3.3%
Q1 25
4.3%
5.0%
Q4 24
5.9%
8.2%
Q3 24
2.4%
13.3%
Q2 24
1.6%
11.8%
Cash Conversion
FTNT
FTNT
ONC
ONC
Q1 26
2.02×
Q4 25
1.23×
6.28×
Q3 25
1.38×
3.22×
Q2 25
1.03×
2.79×
Q1 25
1.99×
34.71×
Q4 24
0.91×
Q3 24
1.13×
Q2 24
0.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FTNT
FTNT

Service$1.2B65%
Product$645.1M35%

ONC
ONC

Segment breakdown not available.

Related Comparisons